Lupin launches Mycophenolic Acid Delayed-Release Tablets USP EP News Bureau Apr 6, 2020 Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg, is the generic equivalent of Myfortic Delayed-Release Tablets,…
Lupin’s partner Concord gets US FDA nod to market Myfortic tablet Press Trust of India Dec 20, 2019 The tablets are indicated for prophylaxis of organ rejection in adult patients receiving kidney transplants Lupin said its…
